Amber Basinger is Director of Business Development at Ardena, focused on building strategic partnerships and supporting biotech and pharmaceutical companies across the Southern United States through Ardena’s integrated CDMO services. She brings more than 11 years of experience in business development within the life sciences industry.
Throughout her career, Amber has built strong relationships with emerging and established pharmaceutical organizations by supporting complex drug development and manufacturing programs. At Ardena, she works closely with clients to align development and manufacturing strategies with evolving program needs, supporting projects from early development through commercialization.
Prior to joining Ardena, Amber served as an Account Executive on Catalent’s Early Phase Small Molecule team, supporting clients across early-stage drug development initiatives.
